background
tobaccorel
lung
diseas
includ
chronic
obstruct
pulmonari
diseas
copd
major
caus
lungrel
disabl
death
worldwid
acut
exacerb
copd
aecopd
commonli
associ
upper
lower
respiratori
tract
viral
infect
result
respiratori
failur
advanc
lung
diseas
object
sought
determin
mechan
underli
copd
exacerb
host
respons
pathogenderiv
factor
method
period
assess
viral
caus
upper
lower
respiratori
tract
infect
patient
copd
n
control
subject
n
collect
nasal
bronchoalveolar
lavag
fluid
peripher
blood
baselin
exacerb
condit
determin
effect
human
rhinoviru
hrv
proteinas
tcell
activ
human
subject
mice
result
hrv
isol
nasal
lung
fluid
subject
aecopd
bronchoalveolar
lavag
fluid
cell
patient
copd
exhibit
h
h
cell
cytokin
phenotyp
acut
infect
hrvencod
proteinas
activ
monocytederiv
dendrit
cell
vitro
induc
strong
h
h
immun
respons
cell
intranas
administr
recombin
rhinoviru
proteinas
mice
result
increas
airway
hyperreact
lung
inflamm
ifng
product
cell
conclus
find
suggest
patient
sever
copd
show
h
h
respons
aecopd
hrvencod
proteinas
like
microbi
proteinas
could
provid
h
h
adjuv
factor
upper
lower
respiratori
tract
infect
patient
sever
copd
alter
immun
respons
secret
viral
proteinas
might
contribut
worsen
dyspnea
respiratori
failur
patient
copd
j
allergi
clin
immunol
chronic
obstruct
pulmonari
diseas
copd
character
irrevers
reduct
maximum
expiratori
airflow
current
fourth
lead
caus
death
unit
state
worldwid
copd
preval
diseas
estim
increas
fifth
preval
next
decad
frequent
hospit
clinicbas
visit
treatment
episod
worsen
short
breath
account
larg
proport
medic
expenditur
portend
poor
outcom
patient
copd
respiratori
tract
infect
lead
caus
morbid
hospit
antibiot
use
patient
chronic
lung
diseas
particular
copd
howev
past
caus
agent
respons
respiratori
failur
remain
obscur
case
viral
infect
evok
strong
h
respons
cytotox
tlymphocyt
respons
requir
effici
erad
organ
howev
number
respiratori
virus
includ
human
rhinovirus
hrv
associ
compar
weak
h
immun
robust
h
allerg
inflamm
h
immun
previous
link
immunopatholog
copd
emphysema
whether
respiratori
tract
viral
infect
exacerb
h
immun
evok
aberr
system
lungspecif
h
respons
remain
unclear
major
difficulti
understand
caus
acut
exacerb
copd
aecopd
mechan
mechan
respiratori
failur
occur
acut
worsen
airway
obstruct
patient
advanc
copd
clearli
link
increas
work
breath
reminisc
ae
asthma
other
shown
presenc
activ
proteinas
environment
relev
allergen
critic
develop
allerg
respons
induc
symptom
airway
obstruct
human
subject
experiment
asthma
inde
neutral
proteinas
render
allergen
inact
absenc
proteolyt
activ
allergen
induc
requisit
lung
h
respons
previous
demonstr
dendrit
cell
dc
activ
allergen
proteinas
induc
h
cell
differenti
studi
investig
whether
host
immun
respons
rhinovir
proteinas
could
contribut
immunopatholog
diseas
exacerb
link
acut
viral
infect
patient
copd
show
hrv
link
aecopd
person
advanc
lung
diseas
moreov
demonstr
rhinovir
proteinas
proteinas
potent
immunomodulatori
activ
human
dc
favor
product
h
h
cytokin
cell
peripher
system
rhinovir
proteinas
induc
allerg
diseas
mice
administ
upper
respiratori
tract
togeth
find
support
mechan
aecopd
proteinas
deriv
rhinoviru
potenti
virus
could
creat
allerg
lung
immun
environ
lead
airway
obstruct
induc
h
h
cellderiv
cytokin
clinic
demograph
characterist
subject
shown
tabl
avail
articl
onlin
repositori
wwwjacionlin
org
recruit
subject
part
longitudin
exacerb
studi
copd
lescopd
time
enrol
subject
free
respiratori
symptom
histori
antibiot
use
system
corticosteroid
past
week
peripher
blood
nasal
throat
swab
sampl
collect
subject
initi
enrol
time
aecopd
copd
exacerb
defin
respiratori
ill
mark
presenc
symptom
rhiniti
pharyng
increas
cough
short
breath
sputum
product
andor
chang
sputum
color
presenc
absenc
fever
temperatur
subject
underw
bronchoscopi
clinic
stabl
altern
patient
admit
ben
taub
gener
hospit
diagnosi
aecopd
start
ventil
support
underw
bronchoscopi
alveolar
fluid
lavag
sampl
describ
previous
studi
approv
institut
review
board
baylor
colleg
medicin
written
inform
consent
obtain
studi
particip
nasal
throat
swab
sampl
collect
lescopd
particip
see
tabl
time
entri
studi
baselin
episod
aecopd
use
commerci
avail
rapid
multiplex
pcr
system
multicodeplx
system
eragen
bioscienc
madison
wi
detect
set
respiratori
virus
includ
hrv
respiratori
syncyti
viru
parainfluenza
viru
influenza
viru
metapneumoviru
adenoviru
coronaviru
enteroviru
accord
manufactur
instruct
describ
previous
bronchoalveolar
lavag
bal
fluid
sampl
obtain
intub
subject
admit
medic
intens
care
unit
ben
taub
gener
hospit
aecopd
patient
clinic
stabl
copd
control
subject
describ
previous
detect
cytokin
bal
fluid
pbmcderiv
cell
concentr
cytokin
bal
fluid
detect
use
antibodybas
standard
elisa
luminex
assay
briefli
total
protein
bal
sampl
measur
sampl
normal
lowest
protein
concentr
use
standard
protein
measur
assay
pierc
bca
protein
assay
thermo
scientif
waltham
mass
standard
elisa
detect
biorad
laboratori
hercul
calif
beadlyt
multiplex
assay
millipor
charlottesvil
va
cytokin
detect
use
measur
supernat
concentr
ifng
accord
manufactur
specif
r
system
minneapoli
minn
bd
bioscienc
franklin
lake
nj
analysi
vitro
tcell
activ
use
tcell
deplet
pbmc
well
irradi
rad
use
antigenpres
cell
final
volum
ml
cocultur
autolog
cell
day
supernat
remov
well
store
batch
cytokin
analysi
biorad
laboratori
monocytederiv
dendrit
cell
modc
gener
previous
describ
cell
posit
select
pbmc
isol
subject
evid
aecopd
use
microbead
separ
automac
miltenyi
biotec
bergisch
gladbach
germani
induc
dc
differenti
cell
cultur
complet
medium
rpmi
fb
iuml
human
rgmcsf
r
system
iuml
human
r
system
co
day
nonadher
immatur
dc
harvest
mean
gentl
pipet
wash
pb
experi
modc
cultur
mgml
lp
mgml
recombin
rhinoviru
proteinas
buffer
vehicl
control
hour
surfac
express
dc
matur
marker
hladr
detect
fluorescein
isothiocyan
phycoerythrin
allophycocyaninconjug
antihladr
mab
respect
bd
bioscienc
analyz
multicolor
facscalibur
flow
cytomet
bd
bioscienc
flowjo
softwar
describ
rhinovir
proteinas
obtain
use
recombin
protein
previous
describ
cell
posit
select
microbead
miltenyi
biotec
use
automac
accord
manufactur
instruct
cocultur
autolog
modc
condit
proteinas
proteinas
lp
buffer
ratio
day
plate
expand
cell
wash
stimul
immobil
mab
hour
cultur
supernat
collect
cytokin
product
assess
use
beadlyt
multiplex
assay
millipor
temecula
calif
wildtyp
mice
purchas
baylor
center
compar
medicin
facil
kept
associ
assess
accredit
laboratori
anim
careaccredit
transgen
anim
facil
baylor
colleg
medicin
experi
perform
accord
protocol
approv
institut
anim
care
use
committe
baylor
colleg
medicin
mice
given
mg
chicken
egg
ovalbumin
ova
mg
intranas
rhinovir
proteinas
proteinas
vehicl
buffer
pb
everi
day
total
day
twentyfour
hour
last
challeng
mice
anesthet
intub
tail
intraven
line
start
respiratori
system
resist
measur
use
provoc
concentr
acetylcholin
milligram
per
gram
caus
increas
airway
resist
baselin
pc
describ
previosuli
lung
wash
two
aliquot
steril
pb
tracheal
cannula
bal
fluid
total
differenti
cell
count
measur
use
standard
hemocytomet
giemsa
stain
cytospin
slide
lungderiv
singl
cell
use
elispot
cultur
supernat
collect
day
co
store
batch
analysi
use
elisa
biorad
multiplex
beadbas
cytokin
detect
kit
previous
describ
recombin
protein
captur
antibodi
correspond
biotinconjug
detect
antibodi
purchas
r
system
bd
bioscienc
ifng
tnf
concentr
measur
use
lincoplex
millipor
glycoprotein
measur
lung
lavag
fluid
describ
previous
comparison
control
copd
bal
fluid
tcell
cytokin
chemokin
concentr
analysi
use
anova
wilcoxon
match
pair
test
nonparametr
comparison
unpair
data
mannwhitney
test
nonparametr
use
respiratori
virus
among
import
trigger
aecopd
therefor
determin
viral
caus
upper
lower
respiratori
tract
infect
prospect
volunt
particip
lescopd
studi
collect
nasal
throat
swab
sampl
volunt
initi
enrol
time
aecopd
see
method
section
definit
aecopd
respiratori
tract
viral
infect
identifi
use
highthroughput
multiplexbas
assay
simultan
identifi
respiratori
virus
subtyp
multicodeplx
eragen
bioscienc
total
ill
episod
period
includ
subject
seen
acut
ill
identifi
found
consist
observ
other
prior
observ
major
exacerb
occur
advanc
copd
global
initi
chronic
obstruct
lung
diseas
gold
class
iiiiv
case
compar
subject
mild
copd
gold
class
iii
case
diseas
control
subject
case
sampl
volunt
baselin
time
entri
lescopd
yield
pcr
evid
viral
infect
contrast
sampl
collect
return
visit
aecopd
pcr
posit
virus
major
rhinoviru
see
tabl
avail
articl
onlin
repositori
wwwjacionlineorg
addit
bal
fluid
sampl
intub
subject
aecopd
posit
respiratori
tract
viral
infect
see
tabl
thu
common
respiratori
virus
especi
hrv
specif
link
presenc
aecopd
stabl
diseas
condit
lymphocyt
extract
lung
parenchyma
patient
moderatetosever
copd
spontan
secret
predomin
h
cytokin
chemokin
understand
lung
immun
profil
aecopd
determin
cytokin
profil
bal
fluid
normal
total
protein
concentr
patient
copd
stabl
exacerb
condit
compar
control
subject
fig
contrast
find
peripher
lung
lymphocyt
studi
vitro
found
half
subject
group
detect
ifng
bal
fluid
although
higher
concentr
cytokin
detect
subject
aecopd
reach
statist
signific
fig
similarli
differ
concentr
bal
fluid
found
fig
b
howev
detect
significantli
higher
concentr
canon
h
cytokin
bal
fluid
subject
aecopd
wherea
subject
group
produc
cytokin
fig
c
latter
find
unexpect
other
previous
shown
lung
immun
phenotyp
subject
stabl
copd
emphysema
highli
h
bias
cell
extract
lung
patient
copd
emphysema
specif
secret
nonetheless
higher
concentr
monokin
induc
gamma
interferon
ifninduc
protein
h
chemokin
induc
ifng
present
bal
fluid
subject
aecopd
fig
e
togeth
data
reconcil
lack
ifng
bal
fluid
previou
find
patient
copd
h
immun
respons
aecopd
find
suggest
h
immun
respons
aris
set
aecopd
possibl
influenc
respiratori
function
next
determin
whether
immun
phenotyp
peripher
blood
cell
isol
aecopd
alter
compar
subject
baselin
condit
spontan
cytokin
releas
pbmcderiv
cell
determin
cocultur
autolog
antigenpres
cell
distinct
condit
baselin
free
respiratori
symptom
exacerb
episod
determin
tcell
immun
respons
time
respiratori
tract
infect
compar
cytokin
baselin
upper
lower
respiratori
tract
infect
control
group
copd
exacerb
mildtomoder
copd
class
iii
advanc
copd
class
iiiiv
diseas
group
defin
revis
gold
criteria
cultur
cell
baselin
time
upper
lower
respiratori
tract
infect
subject
copd
control
subject
aecopd
patient
mildtomoder
copd
class
iii
show
signific
chang
product
ifng
fig
b
wherea
product
significantli
increas
time
respiratori
tract
infect
mildtomoder
diseas
p
fig
b
despit
lack
detect
ifng
bal
fluid
patient
aecopd
pbmcderiv
cell
advanc
lung
diseas
copd
class
iiiiv
secret
significantli
higher
amount
ifng
compar
stabl
condit
p
p
respect
fig
c
agreement
h
cytokin
find
bal
fluid
analys
patient
aecopd
pbmcderiv
cell
aecopd
patient
copd
class
iii
iv
secret
significantli
higher
amount
compar
level
seen
group
stabl
period
fig
c
p
could
detect
express
vitro
cocultur
condit
indic
extrem
low
concentr
cytokin
physiolog
condit
find
indic
h
cytokin
name
h
cytokin
ifng
associ
local
system
immun
respons
patient
advanc
copd
present
upper
lower
respiratori
tract
infect
next
sought
examin
mechan
mechan
underli
induct
h
h
cell
viral
infect
chose
studi
rhinoviru
proteinas
allergen
potenti
microbi
proteinas
establish
link
aecopd
case
rhinoviru
infect
condit
modc
stimul
hour
respons
rhinoviru
proteinas
proteinas
result
signific
upregul
mhc
class
ii
hladr
compar
control
vehicl
lp
stimul
p
p
respect
fig
b
analysi
cytokin
secret
condit
reveal
signific
increas
tnf
product
modc
activ
proteinas
signific
differ
found
secret
fig
c
data
shown
find
indic
viral
proteinas
induc
matur
modc
potenti
alter
function
next
determin
function
signific
rhinoviru
proteinaseactiv
modc
tcell
activ
proteinas
proteinas
lp
activ
modc
induc
greater
secret
ifng
cocultur
cell
fig
find
agreement
bal
fluid
analysi
patient
aecopd
show
signific
h
immun
bia
addit
h
bia
fig
togeth
data
suggest
mechan
rhinoviru
proteinas
induc
matur
activ
human
modc
promot
h
h
cell
differenti
half
subject
group
show
detect
level
ifng
consist
detect
bal
fluid
patient
copd
exacerb
group
compar
control
subject
statist
analysi
perform
mannwhitney
test
data
thu
far
point
direct
contribut
purifi
hrv
proteinas
induct
skew
h
h
immun
respons
human
pbmc
therefor
next
sought
determin
whether
hrv
proteinas
proteinas
could
induc
physiolog
chang
lung
consist
h
respons
mice
therefor
confirm
hrv
proteinas
could
induc
h
immun
respons
h
immun
respons
vivo
administ
ova
pb
ova
vehicl
proteinas
ova
ova
use
ensur
detect
antigenspecif
marker
h
immun
mice
period
use
wellestablish
model
activ
proteinaseinduc
allerg
lung
diseas
proteinas
deliv
intranas
mimic
condit
like
present
activ
hrv
upper
respiratori
tract
infect
fig
compar
ova
vehicl
challeng
intranas
challeng
proteinas
result
airway
hyperreact
assess
increas
respiratori
system
resist
respons
multipl
acetylcholin
dose
decreas
pc
fig
bd
data
shown
rhinoviru
proteinas
induc
robust
lung
inflamm
assess
enhanc
eosinophilia
neutrophilia
wholelung
singlecel
analysi
elispot
techniqu
also
show
predomin
spontan
product
mice
challeng
rhinoviru
proteinas
compar
treatment
group
fig
c
interestingli
despit
robust
h
respons
proteinas
bcell
respons
determin
mean
detect
ovaspecif
present
mice
treat
proteinas
fig
e
analysi
lung
lavag
fluid
group
mice
reveal
increas
glycoprotein
secret
mice
treat
proteinas
fig
f
comprehens
assess
cytokin
profil
elicit
viral
proteinas
lung
cell
cultur
establish
ex
vivo
luminexbas
multiplex
technolog
use
quantifi
secret
cytokin
cell
supernat
studi
show
select
increas
secret
h
cytokin
induc
rhinoviru
proteinas
wherea
h
chemokin
ifng
induc
proteinas
proteinas
stimul
fig
gk
tnf
exclus
upregul
proteinas
fig
l
data
shown
thu
rhinoviru
proteinas
elicit
secret
h
h
cytokin
allerg
lung
diseas
administ
intranas
mice
studi
prospect
investig
associ
respiratori
tract
viral
infect
copd
exacerb
like
mechan
common
respiratori
tract
virus
could
induc
aberr
immun
respons
lung
use
wellcharacter
cohort
former
current
never
smoker
without
advanc
lung
diseas
previous
shown
aecopd
occur
smoker
sever
sever
copd
fev
hrv
among
common
viral
isol
link
respiratori
tract
infect
work
show
bal
fluid
subject
copd
respiratori
failur
show
significantli
higher
concentr
h
chemokin
howev
unexpect
detect
albeit
low
canon
h
cytokin
provid
initi
evid
mix
h
h
respons
elicit
virus
might
contribut
respiratori
failur
seen
patient
rhinovir
proteinas
induc
h
h
cell
develop
naiv
human
cell
effect
modc
power
induc
h
h
cytokin
increas
neutrophil
eosinophil
count
lung
increas
airway
resist
mice
confirm
highli
immunealt
natur
proteinas
togeth
find
suggest
proteinas
produc
hrv
elicit
h
h
respons
might
exacerb
chronic
airway
obstruct
characterist
advanc
copd
potenti
trigger
respiratori
failur
hrv
member
famili
picornavirida
among
common
caus
human
respiratori
tract
infect
hrv
infect
normal
occur
mean
direct
inocul
viru
ciliat
epitheli
cell
upper
airway
bind
host
intercellular
adhes
molecul
result
releas
singlestrand
viral
rna
genom
cytoplasm
h
immun
respons
well
describ
effect
host
immun
respons
erad
viral
infect
howev
asthmat
subject
weak
h
immun
respons
robust
h
immun
rhinoviru
infect
postul
mechan
exacerb
diseas
suscept
asthmat
subject
although
type
immun
long
link
allerg
diseas
occasion
associ
copd
consist
link
type
cytokin
airway
obstruct
smoker
elus
moreov
type
immun
mechan
gener
requir
erad
intracellular
pathogen
virus
inde
preexist
allerg
inflamm
potenti
impair
requisit
viral
clearanc
mechan
essenti
convert
respiratori
virus
selfrepl
allergen
find
rhinovir
proteinas
could
power
induc
h
h
inflamm
thu
provid
potenti
critic
insight
pathogenesi
copd
exacerb
rhinoviru
infect
interest
note
although
found
increas
product
aecopd
specif
subject
sever
sever
copd
gold
class
iiiiv
found
cytokin
gener
inhibitori
h
h
immun
respons
also
upregul
patient
aecopd
irrespect
diseas
sever
increas
level
acut
inflammationinfect
might
repres
natur
regulatori
respons
limit
tcell
activ
initi
viral
infect
nonetheless
induc
lower
respiratori
tract
type
immun
respons
rhinovir
proteinas
like
induc
second
compon
airway
obstruct
mediat
loss
lung
structur
integr
proobstruct
effect
ie
airway
hyperrespons
airway
mucu
hypersecret
moreov
hrv
like
gain
immun
deviat
catalyz
proteinas
asthma
type
immun
induc
viral
proteinas
might
impair
otherwis
effici
type
immun
clearanc
mechan
lead
prolong
infect
enhanc
spread
microorgan
although
point
specul
propos
acceler
product
proteinas
might
evolv
strategi
enhanc
process
polyprotein
interfer
lead
decreas
viral
titer
howev
modul
host
immun
respons
maxim
much
lower
level
proteinas
product
could
promot
diseas
dissemin
although
put
viral
adapt
mechan
littl
consequ
host
normal
respiratori
function
unfortun
peril
sever
copd
respiratori
compromis
clinic
studi
copd
exacerb
shown
inhibit
immun
respons
system
corticosteroid
effect
reduc
length
hospit
shorten
durat
respiratori
failur
find
consist
observ
suggest
aberr
h
immun
respons
superimpos
chronic
type
immun
copd
respons
respiratori
compromis
specif
system
topic
corticosteroid
might
suppress
product
therebi
allevi
airway
hyperrespons
mucu
hyperproduct
induc
cytokin
although
studi
requir
corticosteroid
potenti
promot
elimin
respiratori
virus
inhibit
aberr
allerg
immun
respons
secret
viral
proteinas
ageand
sexmatch
mice
n
group
immun
intranas
ova
recombin
proteinas
proteinas
buffer
pb
everi
day
total
day
hour
last
immun
mice
assess
airway
hyperreact
shown
dose
respons
acetylcholin
use
pc
b
bal
differenti
cell
c
lungspecif
ifng
elispot
ovaspecif
level
serum
e
lung
lavag
glycoprotein
level
f
determin
group
mice
p
rel
pb
buffer
p
rel
proteinas
pb
buffer
use
anova
test
data
repres
mean
sd
concentr
g
h
ifng
j
k
tnf
l
measur
supernat
singlecel
cultur
lung
cell
use
luminex
p
rel
buffer
p
rel
proteinas
buffer
use
anova
test
data
repres
independ
experi
valu
shown
mean
sd
discoveri
allergen
natur
rhinoviru
proteinas
addit
h
respons
expand
list
highli
allergen
proteinas
potenti
relev
human
respiratori
tract
diseas
includ
proteinas
fungal
plant
dust
mite
origin
howev
recent
shown
common
dust
mite
proteinas
isol
human
environ
fail
retain
proteinas
activ
requir
allergen
therefor
environment
proteinas
greatest
proxim
relev
human
respiratori
diseas
might
confin
deriv
plant
fungal
sourc
shown
virus
interestingli
although
studi
reveal
allergen
potenti
multipl
proteinas
also
clear
proteinas
equival
allergen
potenti
perhap
best
exemplifi
rhinovir
proteinas
rel
proteinas
demonstr
weak
allergen
activ
nonetheless
find
support
content
proteinas
crucial
virul
factor
allerg
diseas
elicit
divers
organ
superimposit
allerg
inflamm
preexist
h
diseas
might
expect
compound
airway
obstruct
multipl
nonredund
mechan
therebi
lead
clinic
deterior
regard
find
mix
h
h
immun
patient
aecopd
might
indic
role
host
antigenpres
cell
sens
viral
proteinas
skew
immun
respons
toward
h
exact
mechan
involv
condit
antigenpres
cell
toward
h
respons
current
unknown
remain
intens
area
investig
thank
subject
particip
studi
